Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Other financing activities (2016 - 2020)

Agios Pharmaceuticals (AGIO) has disclosed Other financing activities for 5 consecutive years, with $250.5 million as the latest value for Q2 2020.

  • For Q2 2020, Other financing activities changed N/A year-over-year to $250.5 million; the TTM value through Mar 2021 reached $250.5 million, changed N/A, while the annual FY2020 figure was $250.5 million, N/A changed from the prior year.
  • Other financing activities hit $250.5 million in Q2 2020 for Agios Pharmaceuticals, up from $203000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $250.5 million in Q2 2020 and bottomed at -$727000.0 in Q4 2017.
  • Average Other financing activities over 4 years is $27.8 million, with a median of $124000.0 recorded in 2016.
  • Year-over-year, Other financing activities tumbled 785.85% in 2017 and then soared 199.51% in 2018.
  • Agios Pharmaceuticals' Other financing activities stood at $106000.0 in 2016, then crashed by 785.85% to -$727000.0 in 2017, then soared by 127.92% to $203000.0 in 2018, then surged by 123317.24% to $250.5 million in 2020.
  • According to Business Quant data, Other financing activities over the past three periods came in at $250.5 million, $203000.0, and $188000.0 for Q2 2020, Q2 2018, and Q1 2018 respectively.